Home

Health Catalyst, Inc - Common stock (HCAT)

2.8300
-0.8600 (-23.31%)
NASDAQ · Last Trade: Aug 11th, 12:30 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close3.690
Open2.900
Bid2.910
Ask2.930
Day's Range2.800 - 3.210
52 Week Range2.800 - 9.240
Volume3,211,425
Market Cap131.89M
PE Ratio (TTM)-1.874
EPS (TTM)-1.5
Dividend & YieldN/A (N/A)
1 Month Average Volume615,104

Chart

About Health Catalyst, Inc - Common stock (HCAT)

Health Catalyst Inc is a leading provider of data and analytics technology for healthcare organizations, focused on improving clinical and financial outcomes through its innovative solutions. By leveraging a robust data platform, the company enables healthcare providers to aggregate, analyze, and visualize their data, facilitating better decision-making and operational efficiencies. Health Catalyst's suite of applications and services supports organizations in their journey towards value-based care by enhancing performance improvement initiatives, driving better patient outcomes, and optimizing healthcare delivery systems. Ultimately, the company's mission is to empower healthcare organizations with the insights and tools needed to transform the industry and enhance the quality of care. Read More

News & Press Releases

Why Health Catalyst (HCAT) Stock Is Down Today
Shares of healthcare software provider Health Catalyst (NASDAQ:HCAT) fell 21.5% in the afternoon session after the company reported second-quarter results that met expectations but slashed its full-year revenue forecast and provided a weak outlook for the upcoming quarter. The healthcare software provider’s revenue of $80.72 million and adjusted earnings per share of $0.04 were both in line with Wall Street estimates for the second quarter. However, investors were focused on the future, as the company projected third-quarter revenue of $75 million, which was roughly 12% below analyst expectations. Furthermore, Health Catalyst cut its full-year revenue forecast by 7.5% to $310 million. While the company did beat adjusted EBITDA estimates for the quarter and raised its full-year outlook for the metric, the significant reduction in its revenue guidance overshadowed the positive news, sending shares lower.
Via StockStory · August 8, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · August 8, 2025
Which stocks are moving before the opening bell on Friday?chartmill.com
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · August 8, 2025
Earnings Scheduled For August 7, 2025benzinga.com
Via Benzinga · August 7, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 8, 2025
Health Catalyst (NASDAQ:HCAT) Posts Q2 Sales In Line With Estimates But Stock Drops
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 6.3% year on year to $80.72 million. On the other hand, next quarter’s revenue guidance of $75 million was less impressive, coming in 12% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was in line with analysts’ consensus estimates.
Via StockStory · August 7, 2025
Health Catalyst Reports Second Quarter 2025 Results
SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025.
By Health Catalyst, Inc. · Via GlobeNewswire · August 7, 2025
Health Catalyst (HCAT) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting results this Thursday after market hours. Here’s what you need to know.
Via StockStory · August 5, 2025
Unity, Domo, Five9, Health Catalyst, and Shopify Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the Software as a Service (SaaS) sector rebounded following the sell-off in the previous trading session as a weaker-than-expected U.S. jobs report increased the probability of a Federal Reserve interest rate cut. The July Nonfarm Payrolls (NFP) report showed the U.S. economy added only 73,000 jobs, significantly below the 110,000 forecast. This, combined with downward revisions for May and June, signaled a cooling labor market to investors. In response, market expectations for a September interest rate cut by the Federal Reserve surged from roughly 40% to over 80%. A potential rate cut is generally favorable for growth sectors like technology and SaaS, as lower rates can increase the present value of their future earnings, boosting stock valuations.
Via StockStory · August 4, 2025
1 Value Stock with Solid Fundamentals and 2 Facing Headwinds
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Via StockStory · July 28, 2025
Why Health Catalyst (HCAT) Stock Is Up Today
Shares of healthcare software provider Health Catalyst (NASDAQ:HCAT) jumped 6.6% in the afternoon session after the stock gained ground amid broader positive market sentiment ahead of a busy week for corporate earnings. 
Via StockStory · July 21, 2025
3 Unprofitable Stocks We Approach with Caution
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via StockStory · July 18, 2025
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025
SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
By Health Catalyst, Inc. · Via GlobeNewswire · July 17, 2025
3 Cash-Burning Stocks with Open Questions
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to significant downside.
Via StockStory · July 16, 2025
3 Russell 2000 Stocks in Hot Water
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Via StockStory · July 15, 2025
Deep Dive Into Health Catalyst Stock: Analyst Perspectives (5 Ratings)benzinga.com
Via Benzinga · July 9, 2025
Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
Via StockStory · June 16, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · June 12, 2025
HCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding Uncertainty
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.3% year on year to $79.41 million. On the other hand, next quarter’s revenue guidance of $80.5 million was less impressive, coming in 3.1% below analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Via StockStory · June 11, 2025
Health Catalyst, Steven Madden, Astronics, Wayfair, and Robinhood Shares Are Soaring, What You Need To Know
A number of stocks jumped in the pre-market session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. 
Via StockStory · May 27, 2025
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Question
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · May 26, 2025
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
By Health Catalyst, Inc. · Via GlobeNewswire · May 20, 2025
3 Stocks Under $10 with Questionable Fundamentals
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Via StockStory · May 20, 2025
1 Mooning Stock Worth Your Attention and 2 to Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Via StockStory · May 12, 2025
Breaking Down Health Catalyst: 9 Analysts Share Their Viewsbenzinga.com
Via Benzinga · May 8, 2025